Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JR.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.2.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.58.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDD.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KR.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.64.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KR.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KZ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KS.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDSNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LY.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.5.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.23.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JE.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.83NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.5.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.53.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used